Selecxine
Latest round
- Series B
Last raised
- Mar 2022
Total raised
- $38M
Investors
- 16
About Selecxine
Based in Pohang, South Korea, and founded in 2018, Selecxine operates as a biopharmaceutical development company that develops anti-cancer immunotherapeutics. In 2018, the company was awarded the Innovative Technology Support Award by the Ministry of SMEs and Startups. In 2019, the company developed TCB2 technology, an anti-human interleukin-2 antibody agent. In 2020, Selecxine was again selected as one of the most outstanding companies by the Ministry of SMEs and Startups. In 2021, the company registered a TCB2 patent filing in the USA, Australia, and Russia. The current CEO of the company is Jun-Young Lee. Selecxine develops antibody platform technology for anti-cancer immunotherapeutics. Its main platform technology is SLC-3010, which is an immune-mediated anti-cancer therapeutics for anti-human IL-2 antibody (TCB2).
Who invested in Selecxine
16 investors across 2 rounds
See all investors in Selecxine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Selecxine
Who invested in Selecxine?
Selecxine has 16 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Selecxine raised?
Selecxine has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Selecxine last raise money?
Selecxine's most recent round on record is a Series B, in Mar 2022.
What does Selecxine do?
Based in Pohang, South Korea, and founded in 2018, Selecxine operates as a biopharmaceutical development company that develops anti-cancer immunotherapeutics.
Where is Selecxine headquartered?
Selecxine is headquartered in Pohang, South Korea.
Which VCs invest in companies like Selecxine?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Selecxine's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Selecxine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.